Inhaled Nitric Oxide After Out-of-Hospital Cardiac Arrest

PHASE2TerminatedINTERVENTIONAL
Enrollment

57

Participants

Timeline

Start Date

August 26, 2017

Primary Completion Date

May 22, 2020

Study Completion Date

June 2, 2020

Conditions
Heart Arrest, Out-Of-Hospital
Interventions
DRUG

Nitric Oxide

An endogenous gaseous signaling molecule which stimulates soluble guanylate cyclase and may act via S-nitrosation, nitrite/nitrate or nitrated fatty acid formation.

DRUG

Nitrogen

Nitrogen is the carrier gas (vehicle) for iNO. Subjects receiving placebo will receive equivalent doses of nitrogen.

Trial Locations (5)

15132

UPMC McKeesport, McKeesport

15213

UPMC Presbyterian Hospital, Pittsburgh

15219

UPMC East, Monroeville

UPMC Mercy Hospital, Pittsburgh

15232

UPMC Shadyside, Pittsburgh

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Mallinckrodt

INDUSTRY

lead

Cameron Dezfulian

OTHER